Consolidated Statement Of Cash Flows

Delta-Fly Pharma, Inc. - Filing #7574302

Concept 2022-04-01 to
2022-12-31
2021-04-01 to
2021-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-1,035,896,000 JPY
-835,111,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.